Relief Therapeutics has announced that its NeuroRX-partnered COVID-19 drug RLF-100 met the survival threshold in intensive care patients and added that it expects detailed trial data this year. Relief and NeuroRx are still awaiting the detailed results from rigorous randomised studies of RLF-100 (aviptadil) for the treatment of COVID-19 patients. However, in top-line results from […]

Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure. The topline results came from 45 patients who were assessed, 21 of whom were admitted to an intensive care unit with respiratory failure and critical COVID-19. All patients exhibited […]

2020, the year in which SARS-CoV-2 swept across the globe and plunged humanity into a global pandemic, is slowly drawing to a close. COVID-19 cases have started to climb once more in various corners of the world and the pressing question continues to be: When will we have a vaccine? The answer remains somewhat unclear. […]